PRICE T ROWE ASSOCIATES INC /MD/ - CATABASIS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 59 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$151,000
-28.8%
71,800
-2.0%
0.00%–
Q1 2021$212,000–73,229–0.00%–
 Download
Other shareholders

There were no reported owners of CATABASIS PHARMACEUTICALS IN in Q2 2021.

NameSharesValueWeighting ↓
View complete list of CATABASIS PHARMACEUTICALS IN shareholders